Search Results - "Dai, Shixue"
-
1
Prognosis and personalized treatment prediction in TP53 -mutant hepatocellular carcinoma: an in silico strategy towards precision oncology
Published in Briefings in bioinformatics (20-05-2021)“…Abstract TP53 mutation is one of the most common genetic changes in hepatocellular carcinoma (HCC). It is of great clinical significance to tailor specialized…”
Get full text
Journal Article -
2
Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy
Published in Inflammatory bowel diseases (01-12-2019)“…This article is the first review assessing herbaceous plants as a complementary and alternative therapy in inflammatory bowel disease to provide clinicians…”
Get full text
Journal Article -
3
Environmental and Microbial Factors in Inflammatory Bowel Disease Model Establishment: A Review Partly through Mendelian Randomization
Published in Gut and liver (15-05-2024)“…Inflammatory bowel disease (IBD) is a complex condition resulting from environmental, microbial, immunologic, and genetic factors. With the advancement of…”
Get full text
Journal Article -
4
Tumor necrosis factor alpha blocking agents as treatment for ulcerative colitis intolerant or refractory to conventional medical therapy: a meta-analysis
Published in PloS one (27-01-2014)“…Efficacy of tumor necrosis factor alpha (TNF-α) blockers for treatment of ulcerative colitis that is unresponsive to conventional therapy is unclear due to…”
Get full text
Journal Article -
5
Associations of genetically predicted iron status with 24 gastrointestinal diseases and gut microbiota: a Mendelian randomization study
Published in Frontiers in genetics (07-08-2024)“…Iron status has been implicated in gastrointestinal diseases and gut microbiota, however, confounding factors may influence these associations. We performed…”
Get full text
Journal Article -
6
Artificial liver research output and citations from 2004 to 2017: a bibliometric analysis
Published in PeerJ (San Francisco, CA) (11-01-2019)“…Researches on artificial livers greatly contribute to the clinical treatments for liver failure. This study aimed to evaluate the research output of artificial…”
Get full text
Journal Article -
7
-
8
Dysbiosis of intestinal microbiota in critically ill patients and risk of in-hospital mortality
Published in American journal of translational research (01-01-2021)“…Despite the essential functions of the intestinal microbiota in human physiology, little research was reported on gut microbiota alterations in intensive care…”
Get full text
Journal Article -
9
The effects and predictive value of calcium and magnesium concentrations on nutritional improvement, inflammatory response and diagnosis in patients with Crohn's disease
Published in Journal of human nutrition and dietetics (01-10-2023)“…Crohn's disease (CD) is a progressive inflammatory disease of the gastrointestinal tract associated with malnutrition, high levels of inflammation and calcium…”
Get full text
Journal Article -
10
Circulating leptin levels in the assessment of Crohn's disease activity and its relation to nutritional status
Published in Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral (15-02-2024)“…Objective: to evaluate leptin levels and its relation to nutritional status in Crohn's disease (CD). Methods: the study included 154 CD patients and healthy…”
Get full text
Journal Article -
11
Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Anti-tumour Necrosis Factor Alpha Agents: A Systematic Review and Meta-analysis
Published in Journal of Crohn's and colitis (29-08-2018)“…The association between anti-tumour necrosis factor alpha agents and the risk of lymphoma in patients with inflammatory bowel disease has already been…”
Get full text
Journal Article -
12
Disequilibrium in the CD8.sup.+CD28.sup.+/CD8.sup.+CD28.sup.- T Lymphocyte Balance Is Related to Prognosis in Rats with Trinitrobenzenesulfonic Acid-Induced Colitis
Published in Digestive diseases and sciences (01-03-2017)“…Purpose The CD8.sup.+CD28.sup.+/CD8.sup.+CD28.sup.- T lymphocyte balance is vital for human ulcerative colitis (UC) but has not been defined in experimental…”
Get full text
Journal Article -
13
CD4+CD29+T cells are blamed for the persistent inflammatory response in ulcerative colitis
Published in International journal of clinical and experimental pathology (01-01-2015)“…Ulcerative colitis (UC) is a chronic gastrointestinal disorder eliciting occurrence of colorectal cancer, the third most common human malignancy. The diagnosis…”
Get full text
Journal Article -
14
Disequilibrium in the CD8+CD28+/CD8+CD28− T Lymphocyte Balance Is Related to Prognosis in Rats with Trinitrobenzenesulfonic Acid-Induced Colitis
Published in Digestive diseases and sciences (01-03-2017)“…Purpose The CD8 + CD28 + /CD8 + CD28 − T lymphocyte balance is vital for human ulcerative colitis (UC) but has not been defined in experimental colitis. This…”
Get full text
Journal Article -
15
Disequilibrium in the CD8 super(+)CD28 super(+)/CD8 super(+)CD28 super(-) T Lymphocyte Balance Is Related to Prognosis in Rats with Trinitrobenzenesulfonic Acid-Induced Colitis
Published in Digestive diseases and sciences (01-03-2017)“…The CD8 super(+)CD28 super(+)/CD8 super(+)CD28 super(-) T lymphocyte balance is vital for human ulcerative colitis (UC) but has not been defined in…”
Get full text
Journal Article -
16
Disequilibrium in the CD8^sup +^CD28^sup +^/CD8^sup +^CD28^sup -^ T Lymphocyte Balance Is Related to Prognosis in Rats with Trinitrobenzenesulfonic Acid-Induced Colitis
Published in Digestive diseases and sciences (01-03-2017)“…Purpose The CD8+CD28+/CD8+CD28- T lymphocyte balance is vital for human ulcerative colitis (UC) but has not been defined in experimental colitis. This…”
Get full text
Journal Article -
17
Tumor Necrosis Factor Alpha Blocking Agents as Treatment for Ulcerative Colitis Intolerant or Refractory to Conventional Medical Therapy: A Meta-Analysis: e86692
Published in PloS one (01-01-2014)“…Background Efficacy of tumor necrosis factor alpha (TNF- alpha ) blockers for treatment of ulcerative colitis that is unresponsive to conventional therapy is…”
Get full text
Journal Article